Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease

American Journal of Medical Genetics, Part A

Volumn 143, Issue 8, 2007, Pages 817-823

  Schluterman, Marie K ^a   Krysiak, Amanda E ^a   Kathiriya, Irfan S ^a,b   Abate, Nicola ^a   Chandalia, Manisha ^a   Srivastava, Deepak ^a,b   Garg, Vidu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular malformations; Congenital heart defects; GATA4; Genetics; NKX2.5; Transcription factor

Indexed keywords

AMINO ACID; MUTANT PROTEIN; TRANSCRIPTION FACTOR GATA 4;

AMINO ACID SUBSTITUTION; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; GATA4 GENE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSACTIVATION;

EID: 34147136738     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31652     Document Type: Article

References (31)

1. American Heart Association. 2006. Heart Disease and Stroke Statistics Update. 2006. Dallas: American Heart Association, p 20.
2. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE. 1997. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15:30-35.
3. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S, Smalls O, Johnson MC, Watson MS, Seidman JG, Seidman CE, Plowden J, Kugler JD. 1999. Mutations in the cardiac transcription factor N KX2. 5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567-1573.
4. Bosi G, Garani G, Scorrano M, Calzolari E. IMER Working Party. 2003. Temporal variability in birth prevalence of congenital heart defects as recorded by a general birth defects registry. J Pediatr 142:690-698.
5. Bruneau BG, Nemer G. Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG. 2001. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106:709-721.
6. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN, Trembath RC. 2004. A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 13:2361-2368.
7. Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S, Robinson TE, Dearlove AM, Ribas G, Bonser AJ, Thomas NR, Scotter AJ, Caves LS, Tyrrell GP, Newbury-Ecob RA, Munnich A, Bonnet D, Brook JD. 2005. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 37:423-428.
8. Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. 2005. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 37:161-165.
9. Garg V, Kathiriya IS. Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424:443-447.
10. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. 2005. Mutations in NOTCH1 cause aortic valve disease. Nature 437:270-274.
11. Garg V. 2006. Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci 63:1141-1148.
12. Goldmuntz E, Geiger E, Benson DW. 2001. N KX2. 5 mutations in patients with tetralogy of fallot. Circulation 104:2565-2568.
13. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, Tomita H. Furutani M, Imamura S, Takao A, Nakazawa M, Matsuoka R. 2005. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet Part A 135A:47-52.
14. Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol 39:1890-1900.
15. Kasahara H, Benson DW. 2004. Biochemical analyses of eight N KX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc Res 64:40-51.
16. Kasahara H, Lee B, Schott JJ, Benson DW, Seidman JG, Seidman CE, Izumo S. 2000. Loss of function and inhibitory effects of human CSX/N KX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 106:299-308.
17. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM. 1997. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 11:1048-1060.
18. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH, Gebuhr T, Bullen PJ, Robson SC, Strachan T, Bonnet D, Lyonnet S, Young ID, Raeburn JA, Buckler AJ, Law DJ, Brook JD. 1997. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 15:21-29.
19. McFadden DG, Charite J, Richardson JA, Srivastava D, Firulli AB, Olson EN. 2000. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 127:5331-5341.
20. Modrek B, Lee C. 2002. A genomic view of alternative splicing. Nat Genet 30:13-19.
21. Modrek B, Lee CJ. 2003. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat Genet 34:177-180.
22. Molkentin JD, Kalvakolanu DV, Markham BE. 1994. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol Cell Biol 14:4947-4957.
23. Molkentin JD, Lin Q, Duncan SA, Olson EN. 1997. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11:1061-1072.
24. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M, Bitar F. 2006. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat 27:293-294.
25. Okubo A, Miyoshi O, Baba K, Takagi M, Tsukamoto K, Kinoshita A, Yoshiura K, Kishino T, Ohta T, Niikawa N, Matsumoto N. 2004. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 41 e97.
26. Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, Wilson DB, Watson MS, Hing AV. 1999. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23. 1 and congenital heart disease. Am J Med Genet 83:201-206.
27. Poirier O, Nicaud V, McDonagh T, Dargie HJ, Desnos M, Dorent R, Roizes G, Schwanz K, Tiret L, Komajda M, Cambien F. 2003. Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy. Eur J Hum Genet 11:659-664.
28. Pu WT, Ishiwata T, Juraszek AL, Ma Q, Izumo S. 2004. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 275:235-244.
29. Sarkozy A, Conti E, Neri C, D'Agostino R, Digilio MC, Esposito G, Toscano A, Marino B, Pizzuti A, Dallapiccola B. 2005. Spectrum of atrial septal defects associated with mutations of N KX2. 5 and GATA4 transcription factors. J Med Genet 42:el6.
30. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. 1998. Congenital heart disease caused by mutations in the transcription factor NK X2-5. Science 281:108-111.
31. Sprenkle AB, Murray SF, Glembotski CC. 1995. Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. Circ Res 77:1060-1069.